000			02113 a2200493 4500
005			20250515031059.0
264		0	_c20070405
008			200704s 0 0 eng d
022			_a0893-133X
024	7		_a10.1038/sj.npp.1301119 _2doi
040			_aNLM _beng _cNLM
100	1		_aAchat-Mendes, Cindy
245	0	0	_aImpairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists. _h[electronic resource]
260			_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _cMar 2007
300			_a531-41 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAcetylcysteine _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aBrain Chemistry _xdrug effects
650	0	4	_aCocaine _xadministration & dosage
650	0	4	_aConditioning, Operant _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine _xmetabolism
650	0	4	_aDopamine Agents _xtoxicity
650	0	4	_aDopamine Agonists _xtherapeutic use
650	0	4	_aDopamine Uptake Inhibitors _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Interactions
650	0	4	_aFree Radical Scavengers _xtherapeutic use
650	0	4	_aGene Expression Regulation _xdrug effects
650	0	4	_aGlial Fibrillary Acidic Protein _xmetabolism
650	0	4	_aGlutathione _xmetabolism
650	0	4	_aLearning Disabilities _xdrug therapy
650	0	4	_aMale
650	0	4	_aMethamphetamine _xtoxicity
650	0	4	_aMice
650	0	4	_aNeurotoxicity Syndromes _xcomplications
650	0	4	_aTyrosine 3-Monooxygenase _xmetabolism
700	1		_aAnderson, Karen L
700	1		_aItzhak, Yossef
773	0		_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 32 _gno. 3 _gp. 531-41
856	4	0	_uhttps://doi.org/10.1038/sj.npp.1301119 _zAvailable from publisher's website
999			_c16356791 _d16356791